covid-19 vaccine Health

FDA panel green-lights Moderna COVID boosters for risk groups

Reading now: 794

Vaccine advisors for the Food and Drug Administration (FDA) today unanimously approved a third and smaller dose of Moderna's COVID-19 vaccine for vulnerable groups.Today's meeting of the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) was the first of two days of booster-dose deliberations, which tomorrow will cover the Johnson & Johnson vaccine and mix-and-match strategies.In advance of tomorrow's VRBPAC meetings, a research team based at the National Institutes of Health (NIH) yesterday released a preprint study suggesting that all vaccine combinations were well tolerated and immunogenic, but Johnson & Johnson recipients got a bigger immune response from an mRNA vaccine booster than a second dose of their

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News